Avalayn Pharma found strong investor interest in its inhalable drugs in development for two types of pulmonary fibrosis, enabling the company to upsize its IPO. Data from two mid-stage studies are expected in 2027. The post Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials appeared first on MedCity…
Despite genuine efforts across the industry to reduce protocol complexity, the trend line hasn’t budged. The reasons are partly scientific and operational. And they’re also deeply human. The post Why Protocol Complexity Keeps Increasing – and How to Fix It appeared first on MedCity News.
Technology alone is not the answer to the capacity crisis facing healthcare. But when thoughtfully integrated into care delivery operations, digital tools can help healthcare organizations rebalance workloads and stabilize patient access. The post Repurpose, Don’t Replace: Three Ways Digital Agents Are Improving Phone Access appeared first on MedCity News.
Benefits leaders have become increasingly sophisticated in managing pharmacy spend and high-cost claims. MSK deserves similar strategic attention – not only because it is expensive, but because it is largely preventable. The post Musculoskeletal Disorders Are Draining Employer Health Budgets — The Workplace Itself May Be the Cause appeared first on MedCity News.
The first major update to HIPAA in more than a decade will eliminate the distinction between “required” and “addressable” safeguards, making key cybersecurity and physical security measures mandatory for all healthcare providers. This shift will expose gaps in hospitals’ fragmented security systems, though, according to Kumar Sokka, CEO of cybersecurity platform Acre Security. The post…
Health tech companies made several major funding announcements in April. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in April appeared first on MedCity News.
KalVista Pharmaceuticals brings to Chiesi Group the product Ekterly, the first FDA-approved oral drug for acute treatment of swelling attacks from the rare disease hereditary angioedema. Ekterly’s tablet formulation offers a dosing edge compared to injectable HAE medications. The post Chiesi Group Grows Again in Rare Disease With $1.9B KalVista Acquisition appeared first on MedCity…
Layoffs tied to AI adoption will not be uniform; they will vary by sector, job function, and regulatory exposure. Nowhere is this more complex than in healthcare, where legal constraints, patient safety obligations, and labor dynamics intersect with rapid technological change. The post AI-Driven Layoffs In Healthcare: Navigating Legal Risks and Operational Challenges appeared first…
Financial assistance is moving from discretionary policy to regulated infrastructure. For health systems, that shift has significant operational and financial implications. The post Financial Assistance Reform Is Reshaping Revenue Cycle Strategy appeared first on MedCity News.
In today’s cash- and staffing-strapped, high-stakes healthcare environment, COEs are an operational necessity. The most successful organizations treat them as long-term strategic investments, or engines for scalable, sustainable transformation. The post Beyond Support Teams: The Strategic Role of Centers of Excellence in Healthcare appeared first on MedCity News.